kristina [she/her]@hexbear.net to Science@hexbear.netEnglish · edit-27 months agoGilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.www.cnbc.comexternal-linkmessage-square7fedilinkarrow-up172arrow-down10cross-posted to: news@lemmy.worldmedicine@mander.xyzupliftingnews@lemmit.onlinelgbtq_plus@lemmy.blahaj.zonehealth@lemmy.worldnews@lemmy.world
arrow-up172arrow-down1external-linkGilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.www.cnbc.comkristina [she/her]@hexbear.net to Science@hexbear.netEnglish · edit-27 months agomessage-square7fedilinkcross-posted to: news@lemmy.worldmedicine@mander.xyzupliftingnews@lemmit.onlinelgbtq_plus@lemmy.blahaj.zonehealth@lemmy.worldnews@lemmy.world
minus-squareHexBroke [any, comrade/them]@hexbear.netlinkfedilinkEnglisharrow-up14·edit-27 months agoGilead sold it for $300 a course in India Available for $6 in Australia if low income, otherwise $40 Presumably they’ll do the same or Chinese and Indian manufacturers will just produce it anyway
Gilead sold it for $300 a course in India
Available for $6 in Australia if low income, otherwise $40
Presumably they’ll do the same or Chinese and Indian manufacturers will just produce it anyway